Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
11 NC counties and 1 VA county are under alert, including Mecklenburg, VA and Northampton counties.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neuronetics Inc
(NQ:
STIM
)
0.8499
-0.0283 (-3.22%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Neuronetics Inc
< Previous
1
2
3
4
5
6
Next >
NeuroStar® Marks Two Years of Transformative Impact with NeuroStar University
August 20, 2024
Celebrating milestones in patient care and practice enhancement through NeuroStar’s innovative training facility
From
Neuronetics
Via
GlobeNewswire
Gold Gains Over 1%; Starbucks Shares Move Higher
August 12, 2024
Via
Benzinga
Noninvasive Treatment Provider Neuronetics Agrees To Merge With Canadian Firm Greenbrook TMS; Reports Q2 Earnings And Guidance Below Expectations
August 12, 2024
Neuronetics to acquire Greenbrook TMS (OTC: GBNHF) in an all-stock deal, doubling revenue to $145M. The combined company expects mid-teens growth in 2025 and 2026, with $15M in cost savings and...
Via
Benzinga
Crude Oil Surges 2%; B. Riley Financial Shares Plunge
August 12, 2024
Via
Benzinga
Exposures
Fossil Fuels
Earnings Outlook For Neuronetics
March 04, 2024
Via
Benzinga
STIM Stock Earnings: Neuronetics Misses EPS, Misses Revenue for Q2 2024
August 12, 2024
STIM stock results show that Neuronetics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Dow Dips 150 Points; Monday.com Posts Upbeat Earnings
August 12, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month
August 01, 2024
New initiative aims to provide information and resources for teen mental health amidst rising public health concerns
From
Neuronetics
Via
GlobeNewswire
Aetna Policy Update Expands TMS Availability for Adolescents With Depression
July 22, 2024
Coverage criteria consistent with recent FDA clearance for NeuroStar TMS
From
Neuronetics
Via
GlobeNewswire
3 Neurotech Stocks Bridging Mind and Machine
July 18, 2024
These neurotech stocks stand at the cutting edge of healthcare, but early entrants in new fields tend to be long-term winners.
Via
InvestorPlace
California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults
July 11, 2024
NeuroStar, the first and only TMS treatment cleared for adolescents, now covered by Medi-Cal
From
Neuronetics
Via
GlobeNewswire
BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents
July 10, 2024
Updated criteria post-FDA clearance for NeuroStar TMS benefit youth mental health
From
Neuronetics
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
July 10, 2024
Pre-market stock movers are worth checking out on Wednesday as we break down all of the biggest news worth reading this morning!
Via
InvestorPlace
NeuroStar® Launches Better Me Provider Program Nationwide
July 01, 2024
The first and only TMS company to establish comprehensive standards for patient care and responsiveness in the mental health industry
From
Neuronetics
Via
GlobeNewswire
NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting
June 13, 2024
Early prediction of nonresponse abstract selected for oral presentation as a prestigious Top 4 Abstract at CTMSS 2024
From
Neuronetics
Via
GlobeNewswire
Neuronetics And 3 Other Stocks Under $3 Insiders Are Buying
June 07, 2024
Via
Benzinga
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
May 15, 2024
Policy change comes quickly after FDA clearance for NeuroStar TMS use in ages 15 and older
From
Neuronetics
Via
GlobeNewswire
Nasdaq Moves Lower; Great Lakes Dredge & Dock Shares Surge Following Upbeat Earnings
May 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 07, 2024
Via
Benzinga
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 07, 2024
Via
Benzinga
Crude Oil Edges Lower; UBS Shares Jump After Q1 Earnings
May 07, 2024
Via
Benzinga
Exposures
Fossil Fuels
STIM Stock Earnings: Neuronetics Beats EPS, Beats Revenue for Q1 2024
May 07, 2024
STIM stock results show that Neuronetics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
May 01, 2024
The Company is highlighting stories from adolescents with major depressive disorder on the heels of groundbreaking FDA clearance
From
Neuronetics
Via
GlobeNewswire
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
April 10, 2024
Lack of early symptom improvement is not predictive of final responder status
From
Neuronetics
Via
GlobeNewswire
Top 5 Health Care Stocks That May Plunge In March
March 28, 2024
As of March 28, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Via
Benzinga
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 25, 2024
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 25, 2024
Via
Benzinga
NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
March 25, 2024
NeuroStar is the first and only TMS therapy cleared as an adjunct treatment for patients ages 15 and older
From
Neuronetics
Via
GlobeNewswire
Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
March 07, 2024
From
Neuronetics
Via
GlobeNewswire
Earnings Scheduled For March 5, 2024
March 05, 2024
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.